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Abstract Many studies have demonstrated an association
of both a sedentary lifestyle and a high body mass index
(BMI) with greater risk for cardiovascular disease. Within
the prospective SAPALDIA cohort (Swiss cohort Study on
Air Pollution and Lung Diseases in Adults), we investi-
gated whether regular exercise was protective against
reduced heart rate variability (HRV), a clinically relevant
predictor of cardiovascular morbidity and mortality, and
whether adverse effects of obesity and weight gain on HRV
were modified by regular exercise. Twenty-four-hour
electrocardiograms were recorded in 1,712 randomly
selected SAPALDIA participants aged C50, for whom
BMI was assessed in the years 1991 and 2001–2003. Other
examinations included an interview investigating health
status (especially respiratory and cardiovascular health and
health relevant behaviours including physical activity) and
measurements of blood pressure, body height and weight.
The association between regular physical activity and HRV
and interactions with BMI and BMI change was assessed in
multivariable linear regression analyses. Compared to
sedentary obese subjects, SDNN (standard deviation of all
RR intervals) was 14% (95% CI: 8–20%) higher in sed-
entary normal weight subjects; 19% (CI: 12–27%) higher
in normal weight subjects exercising regularly C2 h/week;
and 19% (CI: 11–28%) higher in obese subjects exercising
regularly C2 h/week. Compared with sedentary subjects
who gained weight, those who gained weight but did
exercise regularly had a 13% higher SDNN (CI: 7–20%).
Regular physical exercise has strong beneficial effects on
cardiac autonomic nervous function and thus appears to
offset the negative effect of obesity on HRV.
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Introduction
Obesity and weight gain are imposing a growing threat to
world health, as in many countries 20–30% of adults are
categorized as clinically obese, and their number is still
increasing (World Health Organization 1999, 2002). Many
studies have demonstrated an association between both a
high body mass index (BMI) and a sedentary lifestyle with
greater risk for cardiovascular disease (Fang et al. 2003;
Wei et al. 1999).
In the SAPALDIA (Swiss cohort Study on Air Pollution
and Lung Diseases in Adults) study of a large sample of
Swiss adults, we confirmed the relation of reduced heart
rate variability (HRV) with increased BMI (Felber Dietrich
et al. 2006). Heart rate variability refers to the beat-to-beat
variation in heart rate and is a marker of cardiac autonomic
control (Kleiger et al. 2005). Reduced HRV predicts
increased risk of cardiovascular disease and mortality in
longitudinal studies (Bigger et al. 1993; Kleiger et al.
1987). Other studies have noted that increased BMI is
associated with reduced HRV, which has been attributed to
decreased adreno-receptor responsiveness, withdrawal of
parasympathetic tone and/or increased sympathetic activity
(Fraley et al. 2005; Ramaekers et al. 1998). Likewise,
weight changes have been associated with changes in HRV
(Hirsch et al. 1991; Poirier et al. 2003). There is also
evidence from the literature that regular moderate endur-
ance training as opposed to strength training has a positive
effect on HRV (Hottenrott et al. 2006). Based on these
findings, we wanted to test the hypothesis within the pro-
spective SAPALDIA cohort that regular exercise is
associated with improved HRV, and that adverse effects of
obesity and weight gain on HRV can be modified by reg-
ular exercise.
Methods
This study is part of the SAPALDIA cohort study, which
was primarily designed to assess health effects from long-
term exposure to air pollutants in the Swiss adult popula-
tion. Details of its design and objectives have been reported
elsewhere (Ackermann-Liebrich et al. 2005; Martin et al.
1997). In brief, a random sample of the Swiss adult pop-
ulation was recruited in 1991 from eight areas featuring
distinct geographical and environmental conditions. A total
of 9,651 participants received intensive health exam-
inations and a detailed health interview in 1991. In
2001–2003, we were able to re-examine 8,047 of the ori-
ginal participants and assess HRV in a random selection
(n = 1,846: 955 women, 891 men) of the 4,417 partici-
pants aged C50 years by 24-h ECGs. Exclusion criteria
were as follows: general or spinal anaesthesia within
8 days prior to the ambulatory ECG recording (n = 5),
having had a myocardial infarction within 3 months prior
to the examination (n = 2), and taking digitalis (n = 6);
nobody had an artificial pacemaker. Exclusion of record-
ings showing atrial fibrillation (n = 12), recordings of
\18 h [recommendations of the Task Force of the Euro-
pean Society of Cardiology and the North American
Society of Pacing and Electrophysiology (1996)] (n = 73),
and recordings of insufficient quality (n = 6) left 1,742
datasets. We had complete information on 1,718 subjects
for analysis of HRV involving BMI and exercise and on
1,712 subjects for analysis involving weight gain from
baseline to follow-up. For statistical reasons, 15 subjects
being underweight at follow-up were excluded from anal-
yses where BMI was used as a categorical variable, leaving
1,703 records for analyses.
HRV measurements and analyses
For the Holter recording, digital devices (Aria, Del Mar
Medical Systems, Irvine, CA, USA) with a frequency
response of 0.05–40 Hz and a resolution of 128 samples/s
were used. Three leads (V1, altered V3 with the electrode
on the left midclavicular line on the lowest rib, and altered
V5 with the electrode on the left anterior axillary line on
the lowest rib) were recorded over 24 h. The mean duration
of the Holter recordings was 22.3 (SD 2.1) h.
All recordings were scanned through a StrataScan 563
(Del Mar) and interpreted using the interactive method,
with a final visual check on the full disclosure. The length
of each RR interval was manually validated during this
step. Resampling was made at 4 Hz. Spectral analysis was
performed by the fast Fourier transform method. Only
normal-to-normal intervals were used, with intervals
excluded due to ectopy or artefacts being replaced by
holding the previous coupling interval level throughout the
time interval to the next valid coupling interval. The
standard deviation of all normal RR (NN) intervals
(SDNN), which is a summary measure of HRV and the
following frequency domain variables have been calcu-
lated: total power (TP) (B0.40 Hz), LF power (0.04–
0.15 Hz), high frequency (HF) power (0.15–0.40 Hz) and
the LF/HF ratio. HF power is an index of the parasympa-
thetic modulation of heart rate, whereas LF power is an
index of the combined parasympathetic and sympathetic
modulation of heart rate. LF/HF represents the sympatho-
vagal balance (North American Society of Pacing and
Electrophysiology 1996; Sztajzel 2004).
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In order to avoid a biased result due to methacholine
challenge, which was part of the SAPALDIA lung function
testing and which, for practical reasons, was performed
before the Holter recording, we excluded the first 2 h of all
recordings (van der Woude et al. 2004).
Holter recordings were made between August 2001 and
March 2003. Recorders were placed on participants having
given consent after a detailed health interview. Participants
were asked to follow their regular daily routine and to
complete a time-activity diary during the recording period.
Other measurements
Body height and weight were measured with participants
not wearing any shoes or coats and body mass index was
calculated as weight (kg) divided by height squared (m2).
Four BMI groups were distinguished according to the
WHO definitions (World Health Organization 1999):
underweight (\18.5 kg/m2), normal weight (18.5–24.9 kg/
m2), overweight (25.0–29.9 kg/m2) and obese (C30 kg/
m2). In the 1991 cross-sectional study, body weight was
asked. Weight gain was defined as being in a higher BMI
category in the follow-up study compared to the first
survey.
The amount of physical activity (Question: ‘How many
hours a week do you usually exercise such that you get out
of breath or sweat?’) (The European Community Respira-
tory Health Survey II 2000) and data on smoking,
education, diabetes, level of daytime sleepiness (Epworth
sleepiness scale) (Johns 1991, 1993) and current medica-
tions status were assessed during a standardized interview
which was led by trained fieldworkers. The participants
were divided into tertiles of exercise: no regular physical
exercise, 1/2–1 h and C2 h of regular physical exercise.
Blood pressure was measured twice at rest in the sitting
position on the left upper arm by an automatic device
(705CP, OMRON, Tokyo, Japan) according to WHO rec-
ommendations (World Health Organization 1996). Blood
pressure values used in the regression model were obtained
by averaging the two measurements. Having high blood
pressure was defined as either having a systolic blood
pressure [140 mmHg, or a diastolic blood pressure
[90 mmHg, or having answered yes to the question ‘‘Do
you have the following condition: Hypertension?’’.
The highest degree of education was used as a proxy for
social position.
Blood samples were taken from the subjects and known
cardiovascular risk factors have been determined by the
Institute for Clinical Chemistry of the University Hospital
Zu¨rich: a Hitachi Modular Autoanalyser (Rotkreuz, Swit-
zerland) and assays from Roche Diagnostics (Mannheim,
Germany) have been used to measure serum levels of uric
acid, triglycerides and total cholesterol (all enzymatic
tests). High sensitive C-reactive protein (CRP) was mea-
sured using a latex-enhanced immunoturbidimetric assay.
High-density lipoprotein cholesterol (HDL) was measured
with a homogenous assay (Roche diagnostics, Mannheim,
Germany) using Roche Cobas Integra (Rotkreuz, Switzer-
land). HDL values were only used if the participants had a
triglyceride level of 9.4 mmol/L or lower. As additional
atherogenic markers, the difference between total choles-
terol and HDL (non-HDL-cholesterol) and the ratio
between total cholesterol and HDL were calculated.
Ethical approval for the study was given by the central
Ethics Committee of the Swiss Academy of Medical Sci-
ences and the Cantonal Ethics Committees for each of the
eight examination areas and subjects signed an informed
consent at the examination.
Statistical methods
Because an initial inspection suggested that the distribution
of the residuals was skewed, the HRV-values were log-
transformed for further analysis and the results are pre-
sented as percent difference between the exposure groups
as well as geometric means.
To calculate the effect of BMI and physical activity on
HRV, we used a multivariable regression model including
variables known from a previous study to influence HRV
(study site, sex, age and age squared, education, self-
reported diabetes, hypertension, smoking status and beta-
blocker intake in the previous 30 days) (Felber Dietrich
et al. 2006).
We investigated modification of the effect of BMI by
physical activity by introducing according interactions
terms between exercise and BMI categories into the mul-
tivariable regression model.
Sensitivity analyses screening for additional potential
confounders (Epworth sleepiness score [10 vs B6;
diuretics, sympathomimetics, calcium-channel blockers
and angiotensin converting enzyme inhibitor intake during
the previous 30 days; non-HDL-cholesterol, uric acid and
high sensitive CRP levels) were carried out.
Statistical analyses were performed using Stata 9.2
(Stata corporation, College Station, TX).
Results
Mean age of the population was 60 years (50–73 years).
Baseline characteristics of the 1,703 study participants by
exercise category are given in Table 1. A sum of 37% of
the study population were of normal weight, 43% were
overweight, and 20% obese, with a homogeneous distri-
bution across exercise categories. Less than 1% of the
study participants were morbidly obese. Between the first
Eur J Appl Physiol (2008) 104:557–565 559
123
and the second survey, 35% had gained weight so that they
changed into a higher BMI category. There were a higher
proportion of women and current smokers in the normal
weight group, but fewer subjects with diabetes or subjects
taking beta-blockers, diuretics or angiotensin converting
enzyme (ACE) inhibitor. In that same group, subjects had
lower average heart rate and systolic and diastolic blood
pressure, and they were on average better educated and
slightly younger; they also had lower levels of non-HDL-
cholesterol, uric acid or CRP.
Table 2 exhibits the adjusted means of HRV parameters
for different BMI and exercise categories. Within each
BMI category, subjects regularly exercising C2 h per week
had higher HRV than sedentary subjects. Even obese
subjects exercising C2 h had a higher HRV than sedentary
normal weight subjects.
Using a cubic model for BMI (continuous), subjects who
exercise regularly had higher SDNN than their sedentary
peers (online supplementary Figure 1 showing curves of
adjusted geometric means for the three exercise catego-
ries). As can be deducted from these curves, SDNN in
physically active subjects (C2 h of exercise per week) did
not depend on BMI.
Figure 1 compares SDNN for obese subjects not exer-
cising (reference group) to other BMI and exercise
categories. Compared to the reference group, overweight
subjects not exercising had an 11% [95% confidence
interval (95% CI: 5–17%)] higher SDNN and normal
weight subjects not exercising had a 14% (95% CI: 8–20%)
higher SDNN.
Regardless of weight, the improvement in SDNN was
greatest for those who exercised regularly C2 h per week.
Compared to the reference group, among those who exer-
cised regularly, SDNN was 19% (95% CI: 12–27%) higher
in normal weight subjects, 18% (95% CI: 12–26%) higher
in overweight subjects, and 19% (95% CI: 11–28%) higher
in obese subjects. The difference in SDNN within each
BMI category between subjects exercising regularly C2 h
and sedentary subjects was highest in obese subjects.
Regular exercise modified the relation of obesity with
SDNN (95% CI: -0.214 to -0.036 for the difference in the
effect of obesity compared to normal weight between
subjects exercising regularly (i.e. C2 h) and subjects with a
sedentary lifestyle) (online supplementary Table 1).
Compared to sedentary obese subjects, obese subjects
exercising regularly also had 29% (95% CI: 9–53%) higher
total power, 29% (95% CI: 0–66%) higher HF, 27% (95%
CI: 4–54%) higher LF (Fig. 2) and a 2% (95% CI: -17 to
16%) lower LF/HF.
Next, we analysed the influence of weight gain between
the first survey and the follow-up survey on HRV. Weight
gain is defined as changing into a higher BMI category, e.g.
Table 1 Baseline
characteristics of the study
population (n = 1,703)
BMI Normal weight Overweight Obese
n 636 (37%) 723 (43%) 344 (20%)
Female sex 400 (63%) 291 (40%) 180 (52%)
Current smokers 135 (21%) 139 (19%) 58 (17%)
Tertiary education 178 (28%) 189 (26%) 67 (20%)
Diabetes 10 (2%) 27 (4%) 34 (10%)
Beta-blocker intake 40 (6%) 88 (12%) 58 (17%)
Higher BMI cat. in follow-up 17 (3%) 348 (48%) 223 (65%)
No regular exercise 264 (42%) 295 (41%) 152 (44%)
1/2–1 h/week exercise 204 (32%) 243 (34%) 113 (33%)
C2 h/week exercise 168 (26%) 185 (26%) 79 (23%)
Symptoms of chronic bronchitis 97 (15%) 115 (16%) 60 (17%)
Diuretic intake 8 (1%) 25 (4%) 27 (8%)
Sympathomimetic intake 11 (2%) 29 (4%) 13 (4%)
Calcium channel blocker 13 (2%) 37 (5%) 31 (9%)
ACE inhibitor intake 23 (4%) 49 (7%) 36 (11%)
Mean heart rate (bpm) 74 (SD 9.7) 74 (SD 9.0) 75 (SD 9.1)
Systolic blood pressure (mmHg) 125 (SD 19.0) 136 (SD 18.6) 138 (SD 17.0)
Diastolic blood pressure (mmHg) 78 (SD 10.2) 84 (SD 10.1) 85 (SD 10.0)
Age (years) 59.4 (SD 6.3) 60.8 (SD 6.2) 61.3 (SD 6.1)
Non-HDL cholesterol (mmol/L) 4.6 (SD 1.1) 4.9 (SD 1.2) 4.8 (SD 1.0)
Uric acid (lmol/L)] 288.1 (SD 75.1) 341.8 (SD 79.9) 359.8 (SD 84.1)
C-reactive protein (mg/L) 1.9 (SD 4.5) 2.5 (SD 5.5) 3.9 (SD 5.5)
Epworth sleep score 6.3 (SD 3.6) 6.4 (SD 3.5) 7.0 (SD 3.8)
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becoming overweight or obese. Compared with subjects
who gained weight and did not exercise regularly, those
who gained weight but did exercise regularly had a 13%
higher SDNN (95% CI: 7–20%), 16% higher total power
(95% CI: 2–32%), 25% higher HF (95% CI: 3–52%), 24%
higher LF (95% CI: 6–44%) and a 1% (95% CI: -14 to
12%) lower LF/HF (Fig. 3).
These associations were not due to a reduction in heart
rate with exercise as there was no evidence for a change
when heart rate was introduced into the models (Table 3).
Mean 24-h heart rate in physically active was 74 bpm
(95% CI: 72–76 bpm) as opposed to 76 bpm (95% CI: 74–
77 bpm) in inactive obese.
Sensitivity analyses
We tested the robustness of the results by including addi-
tional potential confounders into the model. Table 3 shows
that daytime sleepiness, symptoms of chronic bronchitis,
heart rate, cardioactive medication intake or cardiovascular
Table 2 Adjusted geometric mean (GM) of HRV in different exercise categories
BMI Exercise (h/week) Normal weight Overweight Obese
GM 95% CI GM 95% CI GM 95% CI
SDNN (ms) None 131.8 (127.5, 136.3) 128.8 (124.9, 132.8) 115.9 (111.0, 121.1)
1/2–1 135.1 (130.2, 140.2) 131.3 (127.0, 135.8) 127.0 (120.9, 133.5)
C2 138.3 (132.8, 144.0) 137.3 (132.1, 142.8) 137.8 (129.9, 146.2)
Total power (ms2) None 3,733.2 (3,458.6, 4,029.6) 3,459.4 (3,223.6, 3,712.6) 3,018.3 (2,732.1, 3,334.5)
1/2–1 3,816.4 (3,504.8, 4,155.7) 3,689.6 (3,415.7, 3,985.4) 3,517.4 (3,141.0, 3,938.8)
C2 4,081.3 (3,717.0, 4,481.4) 3,725.3 (3,407.3, 4,072.9) 3,904.0 (3,410.0, 4,469.7)
HF (ms2) None 65.1 (58.0, 73.1) 68.6 (61.6, 76.3) 62.0 (53.3, 72.0)
1/2–1 67.1 (59.0, 76.3) 64.4 (57.4, 72.4) 71.0 (59.8, 84.2)
C2 69.1 (60.0, 80.0) 77.1 (67.4, 88.2) 79.8 (65.1, 97.9)
LF (ms2) None 206.6 (188.9, 225.9) 217.7 (200.4, 236.4) 167.4 (148.9, 188.1)
1/2–1 235.2 (212.9, 259.9) 223.2 (203.9, 244.3) 207.4 (181.6, 236.8)
C2 247.4 (221.7, 276.0) 240.0 (216.2, 266.5) 211.9 (180.9, 248.4)
LF/HF None 3.2 (2.9, 3.4) 3.2 (3.0, 3.4) 2.8 (2.5, 3.1)
1/2–1 3.5 (3.2, 3.8) 3.5 (3.2, 3.8) 2.9 (2.6, 3.3)
C2 3.6 (3.3, 3.9) 3.1 (2.8, 3.4) 2.7 (2.3, 3.0)
Adjusted for sex, age, age squared, study site, education, diabetes, hypertension, beta-blocker intake and smoking status
Fig. 1 Compares SDNN for obese subjects not exercising (reference
group) to other subject groups stratified by BMI category (normal,
overweight, obese) and exercise status. Normal weight is defined as
18.5 B BMI \ 25.0 kg/m2; overweight 25.0 B BMI \ 30.0 kg/m2;
obese 30.0 B BMI kg/m2). Effect estimates and 95% confidence
intervals. a Difference to sedentary obese subjects. b Difference to
sedentary overweight subjects (95% CI: -0.196, -0.022). c Differ-
ence to sedentary normal weight subjects (95% CI: -0.214, -0,036)
Fig. 2 Average percent increase and 95% confidence interval in
measures of HRV (SDNN, total power, HF, LF) in obese subjects
exercising C2 h/week, compared to sedentary obese subjects
Eur J Appl Physiol (2008) 104:557–565 561
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risk markers in the blood did not sizeably change the effect
estimates.
We also evaluated whether daytime activity was
responsible for HRV differences between populations with
higher levels of exercise compared to populations with low
levels of exercise. Although the estimates for the sleeping
periods at night were different to the ones for the 24-h
periods, the relation between the different groups was
similar to the one of the 24-h periods, which include active
periods (online supplementary Table 2).
Discussion
This study shows that middle-aged and elderly obese
subjects who were regularly physically active had a higher
HRV than their sedentary peers even after taking into
account the effects of sex, age, study site, education,
diabetes, hypertension, beta-blocker intake and smoking
status. In addition, the improvement in HRV associated
with exercise was similar for obese and normal weight
subjects. Thus, our data suggest that exercise improves
autonomic function as measured by HRV. Analogous to
the recently published results of Sui et al. of their study
on cardiorespiratory fitness and adiposity as mortality
predictors in older adults (Sui et al. 2007), we found that
lower autonomic activity among inactive subjects was
related to body mass index: inactive subjects who were
normal weight had lower HRV than normal weight
exercising subjects, but higher than inactive obese
subjects.
Several potential sources of bias were considered in this
study. Smoking, diabetes or hypertension, all known to
have an impact on HRV (Felber Dietrich et al. 2006), were
controlled for in the baseline analysis. Obesity is also
associated with obstructive sleep apnoea syndrome (OSAS)
(Resta et al. 2001), which in turn, has a strong influence on
the autonomic nervous system (Narkiewicz and Somers
2003). Even more, obese patients with OSAS who lose
weight experience an improvement in the severity of
OSAS, as well as in blood pressure and cardiac autonomic
regulation (Kansanen et al. 1998). We addressed this issue
by additionally controlling for daytime sleepiness in sen-
sitivity analyses but found no indication of such
confounding. Furthermore, we were able to demonstrate
that the observed differences in HRV between groups were
not caused by differences in health status represented by
symptoms of chronic bronchitis, intake of cardioactive
medication or cardiovascular risk markers in the blood. We
also excluded the first 2 h of all recordings in order to
avoid a biased result due to methacholine challenge, after
which full recovery without application of a beta-agonist
takes 33.6 min (1–75 min) (van der Woude et al. 2004).
Being a muscarinic receptor agonist, methacholine would
lead to an increase in high frequency power.
Our findings are consistent with results from interven-
tion trials comparing the beneficial effects of exercise and
weight loss. Oberbach et al. have found that increases in
adiponectin levels after 4 weeks of physical training dis-
proportionally exceeded the beneficial effects of reduced
percent body fat and increased fitness level (Oberbach et al.
2006). In other studies, 3-month aerobic exercise inter-
vention in overweight and obese subjects increased tissue-
type plasminogen activator without evidence of changes in
body mass or adiposity (Van Guilder et al. 2005), and
12 weeks of aerobic training improved insulin sensitivity
in overweight and obese girls without change in body
weight, percent body fat and concentrations of inflamma-
tory markers (Nassis et al. 2005).
Fig. 3 Average percent increase in measures of HRV (SDNN, total
power, HF, LF) in subjects with weight gain exercising C2 h/week,
compared to sedentary subjects with weight gain. Weight gain is
defined as changing to a higher weight category (e.g., becoming
overweight or obese)
Table 3 Sensitivity analyses adding different variables to the base-
line model with the natural logarithm of SDNN as outcome variable
Effect
estimatea (%)
95% CI
Baseline analysis 19 11–28
+ Daytime sleepinessb 23 12–35
+ Symptoms of chronic bronchitisc 19 10–28
+ Heart rate 16 9–24
+Medicationd 19 10–28
+ Cardiovascular risk markers in the bloode 20 11–29
a Estimated %-increase in SDNN associated with regular physical (as
compared to a sedentary way of life) exercise in obese, adjusted for
sex, age, age squared, study site, education, diabetes, hypertension,
beta-blocker intake and smoking status
b Epworth sleepiness score [10 vs. B6
c Questionnaire data: ‘‘regular cough or phlegm, during the day or at
night’’
d Diuretics, sympathomimetics, calcium channel blockers, angioten-
sin converting enzyme inhibitors
e Non-HDL-cholesterol, uric acid, high sensitive C-reactive protein
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There are several limitations of this study. One part of
the study was cross-sectional in design, and hence causality
cannot be inferred from existing associations. However, we
were able to assess weight gain prospectively in the whole
population and the fact that weight gain is showing the
same effect strengthens the argument for a causal
relationship.
Our physical activity data give an overview of the
subjects’ activity during a relatively recent period; they do
not cover lifetime or adulthood exercise. Moreover, they
may include anaerobic exercise. The data on physical
activity were self-reported, as in most epidemiological
studies (US Department of Health and Human Services
1996). Over-reporting of physical activity, the only con-
ceivable form of reporting bias in this context, would have
led to an underestimation of the effect size. Nonetheless,
the physical activity questionnaire that we used has been
previously validated (Washburn et al. 1990), and was used
in other epidemiological studies. The comparative study
concluded that self-reported sweat hours are suitable for
distinguishing active from inactive subjects in epidemio-
logical surveys. Our three activity categories allowed for
such a distinction. In the European Community Respira-
tory Health Survey physical activity level assessed by the
same tool was predictive of bronchial hyperresponsiveness
(Shaaban et al. 2007). Other studies have used other
exercise categories; e.g. the Nurses’ Health Study used
four categories from zero, moderate, to vigorous exercise,
to C4 h/week of vigorous exercise, showing that women
who exercised C4 h/week had a reduced risk for sudden
cardiac death compared to those not being physically
active (Whang et al. 2006). The Women’s Health Study
showed that even as little as 1–1.5 h of light-to-moderate
activity are associated with lower coronary heart disease
rates (Lee et al. 2001), which puts more emphasis on our
results.
A given BMI may not correspond to the same degree of
fatness in different people. In addition, the percentage of
body fat mass is higher in women than in men for equiv-
alent BMI (Ross et al. 1994). However, different studies
have shown that BMI does sufficiently coincide with the
degree of body fatness when adjusting for age and sex
(Gallagher et al. 1996; Movsesyan et al. 2003). Moreover,
the discriminatory power for body fat and lean mass
increases with the value of BMI and is high in obese people
for whom our results are most pronounced (Romero-Corral
et al. 2006).
A major strength of the present study was the large
number of participants. Additionally, detailed information
was available for numerous cardiovascular risk factors,
allowing for control of potential confounders.
In conclusion, our results suggest that regular physical
exercise has strong beneficial effects on cardiac autonomic
nervous function, a clinically relevant predictor of cardio-
vascular morbidity and mortality and that exercise may
offset the negative effect of obesity.
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Bonvin, C. Burrus; Payerne: S. Blanc, A.V. Ebinger, M.L. Fragnie`re,
J. Jordan; Wald: R. Gimmi, N. Kourkoulos, U. Schafroth.
Administrative staff: N. Bauer, D. Baehler, C. Gabriel, R. Gut-
knecht-Nilly.
Holter system technicians: M. Victoire, D. Maudoux.
Mathematical HRV engineering: V. Pichot.
Appendix
SAPALDIA Team
Study directorate: T. Rochat (p), U. Ackermann-Liebrich
(e), J.M. Gaspoz (c), P. Leuenberger (p), L.J.S. Liu (exp),
N.M. Probst Hensch (e/g), C. Schindler (s).
Scientific team: J.C. Barthe´le´my (c), W. Berger (g), R.
Bettschart (p), A. Bircher (a), G. Bolognini (p), O.
Bra¨ndli (p), M. Brutsche (p), L. Burdet (p), M. Frey (p),
M.W. Gerbase (p), D. Gold (e/c/p), W. Karrer (p), R.
Keller (p), B. Kno¨pfli (p), N. Ku¨nzli (e/exp), U. Neu
(exp), L. Nicod (p), M. Pons (p), E. Russi (p), P. Schmid-
Grendelmeyer (a), J. Schwartz (e), P. Straehl (exp), J.M.
Tschopp (p), A. von Eckardstein (cc), J.P. Zellweger (p),
E. Zemp Stutz (e).
Scientific team at coordinating centers: P.O. Bridev-
aux (p), I. Curjuric (e), J. Dratva (e), D. Felber Dietrich (c),
A. Gemperli (s), D. Keidel (s), M. Imboden (g), P. Stae-
dele-Kessler (s), G.A. Thun (g).
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(a) allergology, (c) cardiology, (cc) clinical chemistry,
(e) epidemiology, (exp) exposure, (g) genetic and molec-
ular biology, (m) meteorology, (p) pneumology, (s)
statistics.
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